相似文献
1
Mixed lineage leukemia: a structure-function perspective of the MLL1 protein.
FEBS J. 2010 Apr;277(8):1832-42. doi: 10.1111/j.1742-4658.2010.07609.x. Epub 2010 Mar 4.
2
On the mechanism of multiple lysine methylation by the human mixed lineage leukemia protein-1 (MLL1) core complex.
J Biol Chem. 2009 Sep 4;284(36):24242-56. doi: 10.1074/jbc.M109.014498. Epub 2009 Jun 25.
3
Automethylation activities within the mixed lineage leukemia-1 (MLL1) core complex reveal evidence supporting a "two-active site" model for multiple histone H3 lysine 4 methylation.
J Biol Chem. 2014 Jan 10;289(2):868-84. doi: 10.1074/jbc.M113.501064. Epub 2013 Nov 14.
4
Structural basis for WDR5 interaction (Win) motif recognition in human SET1 family histone methyltransferases.
J Biol Chem. 2012 Aug 10;287(33):27275-89. doi: 10.1074/jbc.M112.364125. Epub 2012 Jun 3.
5
Biochemical reconstitution and phylogenetic comparison of human SET1 family core complexes involved in histone methylation.
J Biol Chem. 2015 Mar 6;290(10):6361-75. doi: 10.1074/jbc.M114.627646. Epub 2015 Jan 5.
6
A non-active-site SET domain surface crucial for the interaction of MLL1 and the RbBP5/Ash2L heterodimer within MLL family core complexes.
J Mol Biol. 2014 Jun 12;426(12):2283-99. doi: 10.1016/j.jmb.2014.03.011. Epub 2014 Mar 27.
7
An Ash2L/RbBP5 heterodimer stimulates the MLL1 methyltransferase activity through coordinated substrate interactions with the MLL1 SET domain.
PLoS One. 2010 Nov 23;5(11):e14102. doi: 10.1371/journal.pone.0014102.
8
Structural basis for the requirement of additional factors for MLL1 SET domain activity and recognition of epigenetic marks.
Mol Cell. 2009 Jan 30;33(2):181-91. doi: 10.1016/j.molcel.2008.12.029.
9
Targeted Disruption of the Interaction between WD-40 Repeat Protein 5 (WDR5) and Mixed Lineage Leukemia (MLL)/SET1 Family Proteins Specifically Inhibits MLL1 and SETd1A Methyltransferase Complexes.
J Biol Chem. 2016 Oct 21;291(43):22357-22372. doi: 10.1074/jbc.M116.752626. Epub 2016 Aug 25.
10
Regulation of MLL1 H3K4 methyltransferase activity by its core components.
Nat Struct Mol Biol. 2006 Aug;13(8):713-9. doi: 10.1038/nsmb1128. Epub 2006 Jul 30.
引用本文的文献
1
Histone methyltransferase KMT2A: Developmental regulation to oncogenic transformation.
J Biol Chem. 2024 Oct;300(10):107791. doi: 10.1016/j.jbc.2024.107791. Epub 2024 Sep 18.
2
The Role of Epithelial-to-Mesenchymal Transition Transcription Factors (EMT-TFs) in Acute Myeloid Leukemia Progression.
Biomedicines. 2024 Aug 21;12(8):1915. doi: 10.3390/biomedicines12081915.
3
Engineering an inducible leukemia-associated fusion protein enables large-scale ex vivo production of functional human phagocytes.
Proc Natl Acad Sci U S A. 2024 Jun 18;121(25):e2312499121. doi: 10.1073/pnas.2312499121. Epub 2024 Jun 10.
4
lncCPSET1 acts as a scaffold for MLL2/COMPASS to regulate Bmp4 and promote the formation of chicken primordial germ cells.
Mol Genet Genomics. 2024 Mar 29;299(1):41. doi: 10.1007/s00438-024-02127-4.
5
Overlapping characteristics of weak interactions of two transcriptional regulators with WDR5.
Int J Biol Macromol. 2024 Feb;258(Pt 2):128969. doi: 10.1016/j.ijbiomac.2023.128969. Epub 2023 Dec 27.
6
RNA binding induces an allosteric switch in Cyp33 to repress MLL1-mediated transcription.
Sci Adv. 2023 Apr 21;9(16):eadf5330. doi: 10.1126/sciadv.adf5330. Epub 2023 Apr 19.
7
Defined Human Leukemic CD34+ Liquid Cultures to Study HDAC/Transcriptional Repressor Complexes.
Methods Mol Biol. 2023;2589:27-49. doi: 10.1007/978-1-0716-2788-4_3.
8
Convergent Alterations of a Protein Hub Produce Divergent Effects within a Binding Site.
ACS Chem Biol. 2022 Jun 17;17(6):1586-1597. doi: 10.1021/acschembio.2c00273. Epub 2022 May 25.
9
Clinical Utility of a Unique Genome-Wide DNA Methylation Signature for -Related Syndrome.
Int J Mol Sci. 2022 Feb 5;23(3):1815. doi: 10.3390/ijms23031815.
10
Kinetics of the multitasking high-affinity Win binding site of WDR5 in restricted and unrestricted conditions.
Biochem J. 2021 Jun 11;478(11):2145-2161. doi: 10.1042/BCJ20210253.
本文引用的文献
1
Mixed lineage leukemia: roles in gene expression, hormone signaling and mRNA processing.
FEBS J. 2010 Apr;277(8):1790-804. doi: 10.1111/j.1742-4658.2010.07606.x. Epub 2010 Mar 4.
2
Mixed lineage leukemia: histone H3 lysine 4 methyltransferases from yeast to human.
FEBS J. 2010 Apr;277(8):1805-21. doi: 10.1111/j.1742-4658.2010.07607.x. Epub 2010 Mar 4.
3
Mixed lineage leukemia: roles in human malignancies and potential therapy.
FEBS J. 2010 Apr;277(8):1822-31. doi: 10.1111/j.1742-4658.2010.07608.x. Epub 2010 Mar 4.
4
WDR5, a complexed protein.
Nat Struct Mol Biol. 2009 Jul;16(7):678-80. doi: 10.1038/nsmb0709-678.
5
On the mechanism of multiple lysine methylation by the human mixed lineage leukemia protein-1 (MLL1) core complex.
J Biol Chem. 2009 Sep 4;284(36):24242-56. doi: 10.1074/jbc.M109.014498. Epub 2009 Jun 25.
6
Regulation of H3K4 trimethylation via Cps40 (Spp1) of COMPASS is monoubiquitination independent: implication for a Phe/Tyr switch by the catalytic domain of Set1.
Mol Cell Biol. 2009 Jul;29(13):3478-86. doi: 10.1128/MCB.00013-09. Epub 2009 Apr 27.
7
Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294.
Nat Struct Mol Biol. 2009 Mar;16(3):312-7. doi: 10.1038/nsmb.1560. Epub 2009 Feb 15.
8
Structural basis for the requirement of additional factors for MLL1 SET domain activity and recognition of epigenetic marks.
Mol Cell. 2009 Jan 30;33(2):181-91. doi: 10.1016/j.molcel.2008.12.029.
9
WDR5 interacts with mixed lineage leukemia (MLL) protein via the histone H3-binding pocket.
J Biol Chem. 2008 Dec 12;283(50):35258-64. doi: 10.1074/jbc.M806900200. Epub 2008 Oct 7.
10
Structure of WDR5 bound to mixed lineage leukemia protein-1 peptide.
J Biol Chem. 2008 Nov 21;283(47):32158-61. doi: 10.1074/jbc.C800164200. Epub 2008 Oct 1.
Zotero 插件